BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35845220)

  • 1. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti-CD19 CAR-T therapy: a case report.
    Mackenzie S; Shafat M; Roddy H; Hyare H; Neill L; Marzolini MAV; Gilhooley M; Marafioti T; Kara E; Sanchez E; Rees J; Lynch DS; Thomson K; Ardeshna KM; Laurence A; Peggs KS; O'Reilly M; Roddie C
    EJHaem; 2021 Nov; 2(4):848-853. PubMed ID: 35845220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
    Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
    N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pembrolizumab for the treatment of Progressive Multifocal Leukoencephalopathy (PML) in a patient with AIDS: A case report and literature review.
    Chatterjee T; Roy M; Lin RC; Almoujahed MO; Ahmad S
    IDCases; 2022; 28():e01514. PubMed ID: 35637642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive Multifocal Leukoencephalopathy After Chimeric Antigen Receptor T-Cell Therapy for Recurrent Non-Hodgkin Lymphoma.
    Ahrendsen JT; Sehgal K; Sarangi S; Uhlmann EJ; Varma H; Arnason J; Avigan D
    J Hematol; 2021 Oct; 10(5):212-216. PubMed ID: 34804310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
    Volk T; Warnatz K; Marks R; Urbach H; Schluh G; Strohmeier V; Rojas-Restrepo J; Grimbacher B; Rauer S
    J Neurol; 2022 Feb; 269(2):973-981. PubMed ID: 34196768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab.
    Boesl F; Allers K; Herm J; Scheider T; Franke C
    J Neurovirol; 2022 Apr; 28(2):335-338. PubMed ID: 35320511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late occurrence of progressive multifocal leukoencephalopathy after anti-CD19 chimeric antigen receptor T-cell therapy.
    Mian A; Andrapalliyal N; Weathers AL; Pohlman B; Hill BT
    Eur J Haematol; 2021 Apr; 106(4):584-588. PubMed ID: 33459429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
    Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
    BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
    Bauer J; Gold R; Adams O; Lassmann H
    Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy.
    Möhn N; Wattjes MP; Adams O; Nay S; Tkachenko D; Salge F; Heine J; Pars K; Höglinger G; Respondek G; Stangel M; Skripuletz T; Jacobs R; Sühs KW
    Ther Adv Neurol Disord; 2021; 14():1756286421993684. PubMed ID: 34035834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
    Holmes A; Wellings T; Walsh O; Rowlings P
    J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pembrolizumab treatment of inflammatory progressive multifocal leukoencephalopathy: a report of two cases.
    Darcy S; Alexander M; McCarthy A; O'Dowd S
    J Neurovirol; 2022 Feb; 28(1):145-150. PubMed ID: 34874539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors.
    Boumaza X; Bonneau B; Roos-Weil D; Pinnetti C; Rauer S; Nitsch L; Del Bello A; Jelcic I; Sühs KW; Gasnault J; Goreci Y; Grauer O; Gnanapavan S; Wicklein R; Lambert N; Perpoint T; Beudel M; Clifford D; Sommet A; Cortese I; Martin-Blondel G;
    Ann Neurol; 2023 Feb; 93(2):257-270. PubMed ID: 36151879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.
    Krey L; Raab P; Sherzay R; Berding G; Stoll M; Stangel M; Wegner F
    Front Immunol; 2019; 10():1188. PubMed ID: 31191548
    [No Abstract]   [Full Text] [Related]  

  • 15. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review.
    Lan TY; Chen YS; Cheng CF; Huang ST; Shen CY; Hsu PN
    Lupus; 2021 Oct; 30(11):1849-1855. PubMed ID: 34325541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China.
    Fan S; Liu M; Bai L; Chen S; Hou B; Lin N; Yuan J; Mao C; Niu J; Ren H; Zhao Y; Zhang Z; Zhu Y; Peng B; Guan H
    J Neurovirol; 2023 Dec; 29(6):692-698. PubMed ID: 37898569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.
    Beck ES; Cortese I
    Curr Opin Virol; 2020 Feb; 40():19-27. PubMed ID: 32279025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?
    Roos-Weil D; Weiss N; Guihot A; Uzunov M; Bellanger A; Eymard B; Saadoun D; Houillier C; Idbaih A; Demeret S; Deback C; Leblond V; Galanaud D; Shor N; Pourcher V
    J Neurol; 2021 Jul; 268(7):2458-2465. PubMed ID: 33515299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive multifocal leukoencephalopathy after CAR T therapy.
    Sdrimas K; Diaz-Paez M; Camargo JF; Lekakis LJ
    Int J Hematol; 2020 Jul; 112(1):118-121. PubMed ID: 32125605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV.
    Pinnetti C; Cimini E; Vergori A; Mazzotta V; Grassi G; Mondi A; Forbici F; Amendola A; Grisetti S; Baldini F; Candela C; Casetti R; Campioni P; Capobianchi MR; Agrati C; Antinori A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.